Infused Chemotherapy Use in the Elderly After Patent Expiration
May 9th 2012As calls for improving the quality and cost efficiency of oncology increase, future empirical work is needed to examine the responsiveness of oncologists' treatment decision making to incentives among patients of all ages and insurance types.
Development of a Multidisciplinary, Multicampus Subspecialty Practice in Endocrine Cancers
May 8th 2012The development of subspecialty tumor groups for uncommon malignancies represents an effective approach to building experience, increasing patient volumes and referrals, and fostering development of increased therapeutic options and clinical trials for patients afflicted with otherwise historically neglected cancers.